How big is Agile Therapeutics, Inc.?

Jun 22 2025 05:50 PM IST
share
Share Via
As of Aug 26, Agile Therapeutics, Inc. has a market capitalization of 10.43 million, with net sales of 21.58 million and a net profit loss of 15.86 million over the last four quarters. The company's shareholder's funds are -16.32 million, and total assets are 10.26 million.
Market Cap: As of Aug 26, Agile Therapeutics, Inc. has a market capitalization of 10.43 million, categorizing it as a Micro Cap company.

Recent Quarterly Performance: For the latest four quarters, Agile Therapeutics reported net sales totaling 21.58 million. However, the company experienced a net profit loss of 15.86 million during the same period.

Balance Sheet Snapshot: As of Dec 23, the company's shareholder's funds stood at -16.32 million, while total assets were reported at 10.26 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Who are in the management team of Agile Therapeutics, Inc.?
Jun 22 2025 10:21 PM IST
share
Share Via
What does Agile Therapeutics, Inc. do?
Jun 22 2025 06:27 PM IST
share
Share Via